A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy

Breast Cancer Research and Treatment

Volumn 40, Issue 2, 1996, Pages 151-159

  Rella, Carmela ^a   Coviello, Maria ^b   Giotta, Francesco ^a   Maiello, Evaristo ^a   Colavito, Paolo ^b   Colangelo, Donatella ^b   Quaranta, Michele ^b   Colucci, Giuseppe ^a   Schittulli, Francesco ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b NONE

Author keywords

Breast cancer; Hemostatic factors; Thrombosis

Indexed keywords

ANTITHROMBIN; CYCLOPHOSPHAMIDE; FIBRINOGEN; FLUOROURACIL; METHOTREXATE; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BLOOD CHEMISTRY; BLOOD CLOTTING; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HYPERCOAGULABILITY; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOSIS;

EID: 0029788505     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806210     Document Type: Article

References (36)

1. Trousseau A: Phlegmasia alba dolens: clinique medicale de l'Hotel-Dieu de Paris, vol 3. New Sydenham Society, London, 1965, pp 695-727
2. Rickles FR, Edwards RL: Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 62: 14-31, 1983
3. Dvorak HF: Thrombosis and cancer. Hum Pathol 18: 275-284, 1987
4. Naschitz JE, Yeshurun D, Lev LM: Thromboembolism in cancer. Cancer 71: 1384-1390, 1993
5. Clarke CS, Otridge BW, Carney DN: Thromboembolism. Cancer 66: 2027-2030, 1990
6. Goldsmith GH Jr: Hemostasis disorders associated with neoplasia. In: Ratnoff OD, Forbes CD (eds) Disorders of hemostasis. Grune and Stratton, Philadelphia, 1984, pp 351-366.
7. Nand S, Fisher SG, Salgia R, Fisher RI: Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications. J Clin Oncol 5: 1998-2003, 1987
8. Rahr HB, Sorensen V: Venous thromboembolism and cancer. Blood Coagul Fibrin 3: 451-560, 1992
9. Edwards RL, Rickles FR, Croulund M: Abnormalities of blood coagulation in patients with cancer: mononuclear cell tissue factor generation. J Lab Clin Med 98: 917-928, 1981
10. Falanga A, Gordon SG: Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue. Biochemistry 24: 5558-5567, 1985
11. Adany R, Kappelmayer J, Beremyi E: Factors of the extrinsic pathway of blood coagulation in tumour associated macrophages. Thromb Haemostas 62: 850-855, 1989
12. Cozzolino F, Torcia M, Miliani A, Carossino AM, Giodani R, Cinotti S, Filimberti E, Saccardi R, Bernabei P, Guidi G, Di Guglielmo R, Pistoia V, Ferrarini M, Nawroth PP, Stern D: Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia. Am J Med 84: 240-250, 1988
13. Bick RL: Alterations of haemostasis associated with malignancy. Etiology, pathophysiology, diagnosis and management. Sem Thromb Hemost 5: 1-26, 1987
14. Weiss RB, Tormey DC, Holland JF, Weinberg VE: Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat Rep 65: 677-679, 1981
15. Goodnough LT, Saito H, Mann A, Jones PK, Pearson DH: Increased incidence of thromboembolism in Stage IV breast cancer patients treated with five drugs. Cancer 54: 1264-1268, 1984
16. Fisher B, Constantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NW, Wolmark N, Wickerham DL, Fisher ER, Margolese R, Robidoux A, Shibata H, Terz J, Paterson AHG, Feldman MI, Farrar W, Evans J, Lickley HL, Ketner M, and others: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. New Engl J Med 320: 479-484, 1989
17. Enck RE, Rios CN: Tamoxifen treatment of metastatic breast cancer and antithrombin III levels. Cancer 53: 2607-2609, 1984
18. Rogers JS II, Murgo AJ, Fontana JA, Faich PC: Chemotherapy for breast cancer decreases plasma protein C and protein S. J Clin Oncol 6: 276-281, 1988
19. von Clauss A: Rapid physiological coagulation method for the determination of fibrinogen. Acta Haemat 17: 237, 1957
20. Levine MN, Gent M, Hirsh J, Arnold A, Goodyear MD, Hryniuk W, De Pauw S: The thrombogenic effect of anticancer drug therapy in women with Stage II breast cancer. N Engl J Med 318: 404-407, 1988
21. Wall JG, Weiss RB, Norton L, Perloff M, Rice MA, Korzun AH, Wood WC: Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B study. Am J Med 87: 501-504, 1989
22. Saphner T, Tormey DC, Gray R: Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9: 286-294, 1991
23. Barbui T, Finazzi G, Viganò S, Mannucci PM: L-Asparaginase lowers protein C antigen. Thromb Haemost 52: 216. 1984
24. Pitney WR, Phadke KP, Dean S: Antithrombin III deficiency during asparaginase therapy. Lancet 1: 493-494, 1980
25. Kucuk O, Kwaan H, Gunnar W, Vazguez R: Thromboembolic complications associated with L-asparaginase therapy. Cancer 55: 702-706, 1985
26. Auger MJ, Mackie MJ: Effects of Tamoxifen on blood coagulation. Cancer 61: 1316-1319, 1988
27. Canobbio L, Fassio T, Adrizzoni A, Bruzzi P, Queirolo MA, Zarcone D, Di Giorgio F, Rosso R, Santi L: Hypercoagulable state induced by cytostatic drugs in Stage II breast cancer patients. Cancer 58: 1032-1036, 1986
28. Feffer SE, Carmosino LS, Fox RL: Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5-fluorouracil. Cancer 63: 1303-1307, 1989
29. Dano K. Andreasen PA, Brondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44: 140-266, 1985
30. Relia C, Ozzello L, Coviello M, Quaranta M, Schittulli F, Kudryk BJ, Donati MB, Bini A: Fibrinolytic components and fibrin(ogen)-related antigens in breast and colon carcinomas. Submitted.
31. Griffin JH, Ekatt B, Zimmermant TS, Kleiss AJ, Wideman C: Deficiencies of protein C in congenital thrombotic disease. J Clin Invest 68: 1370-1373, 1982
32. Bovill EG, Bauer KA, Dickerman JD, Callas P, West B: The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 73: 712-717, 1989
33. Comp PCV, Nixon RR, Cooper MR, Esmon CT: Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 74: 2082-2088, 1984
34. Schwarz HP, Fischer M, Hopmeir P, Batard MA, Griffin JH: Plasma protein S deficiency in familial thrombotic disease. Blood 64: 1297-1300, 1984
35. Dawson S, Henney A: The status of PA1-1 as a risk factor for arterial and thrombotic disease: A review. Atherosclerosis 95: 105-117, 1992
36. Schved JF, Gris JC, Martinez P, Sarlat C, Sanchez N, Arnaud A: Familial thrombophilia associated with familial elevation of plasma histidine rich glycoprotein and type 1 PAL Thromb Haemost 65(6): 1044-1048, 1991